Related Recommend
Product Name |
Flumequine |
||
Applications |
Mainly used in the treatment of metastatic castration - resistant prostate cancer to inhibit the synthesis of androgens and slow down cancer progression. |
||
Typical Properties |
Appearance |
White or almost white crystalline powder, odorless |
|
Specific rotation |
-0.10 0~+0.10 |
||
Distinguish |
TLC |
positive reaction |
|
IR |
Conforms to that of the standard solution |
||
Clarity and color of solution |
Should be confirm |
||
Loss on drying(%) |
≤0.5% |
||
Residue On Ignition(%) |
≤0.1% |
||
Heavy metal |
≤10ppm |
||
Total impurity,% |
≤1.0% |
||
Any other impurity |
≤0.5% |
||
Assay,% |
≥99.1% |
Product Name |
Flumequine |
||
Applications |
Mainly used in the treatment of metastatic castration - resistant prostate cancer to inhibit the synthesis of androgens and slow down cancer progression. |
||
Typical Properties |
Appearance |
White or almost white crystalline powder, odorless |
|
Specific rotation |
-0.10 0~+0.10 |
||
Distinguish |
TLC |
positive reaction |
|
IR |
Conforms to that of the standard solution |
||
Clarity and color of solution |
Should be confirm |
||
Loss on drying(%) |
≤0.5% |
||
Residue On Ignition(%) |
≤0.1% |
||
Heavy metal |
≤10ppm |
||
Total impurity,% |
≤1.0% |
||
Any other impurity |
≤0.5% |
||
Assay,% |
≥99.1% |